Cargando…

Stealth Liposomes (PEGylated) Containing an Anticancer Drug Camptothecin: In Vitro Characterization and In Vivo Pharmacokinetic and Tissue Distribution Study

Numerous attempts to overcome the poor water solubility of cam ptothecin (CPT) by various nano drug delivery systems are described in various sources in the literature. However, the results of these approaches may be hampered by the incomplete separation of free CPT from the formulations, and this i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sivadasan, Durgaramani, Sultan, Muhammad H., Madkhali, Osama Ali, Alsabei, Shahd Hassan, Alessa, Asia Abdullah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838228/ https://www.ncbi.nlm.nih.gov/pubmed/35164350 http://dx.doi.org/10.3390/molecules27031086

Ejemplares similares

Polymeric Lipid Hybrid Nanoparticles (PLNs) as Emerging Drug Delivery Platform—A Comprehensive Review of Their Properties, Preparation Methods, and Therapeutic Applications
por: Sivadasan, Durgaramani, et al.
Publicado: (2021)

Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes
por: Zhai, Bingtao, et al.
Publicado: (2020)

Opsonin-Deficient Nucleoproteic Corona Endows UnPEGylated Liposomes with Stealth Properties In Vivo
por: Giulimondi, Francesca, et al.
Publicado: (2022)

Flurbiprofen-Loaded Stealth Liposomes: Studies on the Development, Characterization, Pharmacokinetics, and Biodistribution
por: Begum, MY, et al.
Publicado: (2012)

Stealth Liposomal Chemotherapeutic Agent for Triple Negative Breast Cancer with Improved Pharmacokinetics
por: Kommineni, Nagavendra, et al.
Publicado: (2022)

PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system
por: Castillo, Paula M, et al.
Publicado: (2014)

Surface Engineering of Liposomes for Stealth Behavior
por: Nag, Okhil K., et al.
Publicado: (2013)

Antibody-Hapten Recognition at the Surface of Functionalized Liposomes Studied by SPR: Steric Hindrance of Pegylated Phospholipids in Stealth Liposomes Prepared for Targeted Radionuclide Delivery
por: Botosoa, Eliot. P., et al.
Publicado: (2011)

Improved pharmacokinetics and reduced toxicity of brucine after encapsulation into stealth liposomes: role of phosphatidylcholine
por: Chen, Jun, et al.
Publicado: (2012)

Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
por: Yuan, Jiani, et al.
Publicado: (2017)

Development and Optimization of Methylcellulose-Based Nanoemulgel Loaded with Nigella sativa Oil for Oral Health Management: Quadratic Model Approach
por: Sultan, Muhammad H., et al.
Publicado: (2022)

Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
por: Anders, Carey K., et al.
Publicado: (2013)

Effect of pegylated phosphatidylserine-containing liposomes in experimental chronic arthritis
por: Urbano, Paulo CM, et al.
Publicado: (2015)

Comparison of Conventional Chemotherapy, Stealth Liposomes and Temperature-Sensitive Liposomes in a Mathematical Model
por: Gasselhuber, Astrid, et al.
Publicado: (2012)

Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation
por: Begum, M. Yasmin, et al.
Publicado: (2022)

Cubosomes in Drug Delivery—A Comprehensive Review on Its Structural Components, Preparation Techniques and Therapeutic Applications
por: Sivadasan, Durgaramani, et al.
Publicado: (2023)

‘Stealth’ Prostate Tumors
por: Wagaskar, Vinayak G., et al.
Publicado: (2023)

Preparation and Characterization of Stealth Archaeosomes Based on a Synthetic PEGylated Archaeal Tetraether Lipid
por: Barbeau, Julie, et al.
Publicado: (2011)

Pharmacokinetics and Anti-Tumor Efficacy of PEGylated Liposomes Co-Loaded with Cisplatin and Mifepristone
por: Ocaña-Arakachi, Karen, et al.
Publicado: (2023)

Sustained delivery of a camptothecin prodrug – CZ48 by nanosuspensions with improved pharmacokinetics and enhanced anticancer activity
por: Dong, Dong, et al.
Publicado: (2019)

Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies
por: Nageeb El-Helaly, Sara, et al.
Publicado: (2017)

PEGylated liposomes: immunological responses
por: Mohamed, Marwa, et al.
Publicado: (2019)

Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood–brain barrier in rats
por: Rip, Jaap, et al.
Publicado: (2014)

Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
por: Immordino, Maria Laura, et al.
Publicado: (2006)

Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes
por: Hsieh, Yuan-Chin, et al.
Publicado: (2018)

Pegylated liposomal doxorubicin in ovarian cancer
por: Green, Andrew E, et al.
Publicado: (2006)

Pegylated liposomal doxorubicin in ovarian cancer
por: Strother, Robert, et al.
Publicado: (2009)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

Evidence of Protein Adsorption in Pegylated Liposomes: Influence of Liposomal Decoration
por: Sangrà, Marc, et al.
Publicado: (2017)

High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours
por: Koukourakis, M I, et al.
Publicado: (2000)

Targeting doxorubicin encapsulated in stealth liposomes to solid tumors by non thermal diode laser
por: Ghannam, Magdy M., et al.
Publicado: (2016)

Inclusion Complex between Local Anesthetic/2-hydroxypropyl-β-cyclodextrin in Stealth Liposome
por: Souza, Gredson Keiff, et al.
Publicado: (2022)

PVA/κ-carrageenan/Au/camptothecin/pegylated-polyurethane/paclitaxel nanofibers against lung cancer treatment
por: Irani, Mohammad, et al.
Publicado: (2022)

The Stealth Virus
por: Tang, Julian W.
Publicado: (2013)

Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors
por: Wu, Huali, et al.
Publicado: (2015)

Computational biotechnology guides elucidation of the biosynthesis of the plant anticancer drug camptothecin
por: Stander, Emily Amor, et al.
Publicado: (2021)

Preparation of a PEGylated liposome that co-encapsulates l-arginine and doxorubicin to achieve a synergistic anticancer effect
por: Feng, Haitao, et al.
Publicado: (2021)

Pegylated liposomal doxorubicin in the management of ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2010)

A tale of the two PEGylated liposomal doxorubicins
por: Chou, Hunghsueh, et al.
Publicado: (2015)

Interactions of primaquine and chloroquine with PEGylated phosphatidylcholine liposomes
por: Miatmoko, Andang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5s5tjmanale9bbq6df0d3t6lin